Table 3.
Change in Body Weight and Composition |
Δ Total Hip BMD (mg/cm2) |
Δ Femoral Neck BMD (mg/cm2) |
Δ Spine BMD (mg/cm2) |
|||
---|---|---|---|---|---|---|
| ||||||
β (95% CI) | p-value | β (95% CI) | p-value | β (95% CI) | p-value | |
Δ Total body weight (kg) | 1.9 (1.5, 2.4) | <0.01 | 0.8 (0.3, 1.3) | <0.01 | 0.4 (−0.3, 1.01) | 0.19 |
Δ Total body lean mass (kg) | 3.8 (2.3, 5.4) | <0.01 | 1.4 (−0.0, 2.8) | 0.06 | −0.00 (−1.8, 1.8) | 0.99 |
Δ Total body fat mass (kg) | 2.8 (2.1, 3.4) | <0.01 | 1.2 (0.5, 1.8) | <0.01 | 0.8 (−0.0, 1.66) | 0.06 |
Δ Leptin (ng/dL)* | 1.2 (0.7, 1.7) | <0.01 | 0.7 (0.3, 1.0) | <0.01 | 0.6 (0.0, 1.1) | 0.04 |
Δ Leptin (ng/dL), further adjusted for fat mass change ** |
0.3 (−0.2, 0.8) | 0.26 | 0.4 (0.0, 0.8) | 0.05 | 0.5 (−0.2, 1.2) | 0.14 |
Δ Leptin (ng/dL), further adjusted for fat mass change ** |
0.3 (−0.2, 0.8) | 0.26 | 0.4 (0.0, 0.8) | 0.05 | 0.5 (−0.2, 1.2) | 0.14 |
Model estimates adjust for randomization group, gender, baseline BMI, and baseline location BMD value.
Statistical significance (p<0.05) unchanged using log-leptin in model in place of leptin except for spine (log-leptin p=0.16).
Nonsignificance (p≥0.05) unchanged using log-leptin in place of leptin.